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Comparison of mortality with home hemodialysis and center hemodi-
alysis: A national study. We sought to determine whether lower mortality
rates reported with hemodialysis (HD) at home compared to hemodialysis
in dialysis centers (center HD) could be explained by patient selection.
Data are from the United States Renal Data System (USRDS) Special
Study Of Case Mix Severity, a random national sample of 4,892 patients
who started renal replacement therapy in 1986 to 1987. Intent-to-treat
analyses compared mortality between home HD (N = 70) and center HD
patients (N = 3,102) using the Cox proportional hazards model. Home
HD patients were younger and had a lower frequency of comorbid
conditions. The unadjusted relative risk (RR) of death for home HD
patients compared to center HD was 0.37 (P < 0.001). The RR adjusted
for age, sex, race and diabetes, was 44% lower in home HD patients (RR
= 0.56, P = 0.02). When additionally adjusted for comorbid conditions,
this RR increased marginally (RR = 0.58,P = 0.03). A different analysis
using national USRDS data from 1986/7 and without comorbid adjust-
ment showed patients with training for self care hemodialysis at home or
in a center (N = 418) had a lower mortality risk (RR = 0.78, P = 0.001)
than center HD patients (N = 43,122). Statistical adjustment for comorbid
conditions in addition to age, sex, race, and diabetes explains only a small
amount of the lower mortality with home HD.
Each year the number of patients with end-stage renal disease
(ESRD) in the United States continues to increase. Information
from the United States Renal Data System (USDS) shows the
prevalence count of treated ESRD has been increasing by 9 to
13% per year and by 1992 there were more than 242,000 prevalent
patients [1]. Hemodialysis rather than peritoneal dialysis remains
the predominant treatment modality in the United States. Among
prevalent dialysis patients in 1992, 81% of patients were being
treated with center hemodialysis and only one percent were
receiving hemodialysis at home. This was not always the case.
Previously a greater proportion of patients were treated with
home hemodialysis, but use of this modality has declined progres-
sively over the last 20 years in the United States.
This decrease in the proportion of patients treated by home
hemodialysis has occurred despite reports of a substantially lower
mortality rate with this modality than either center hemodialysis
or continuous ambulatory peritoneal dialysis (CAPD) [2, 3]. Also,
Received for publication September 8, 1995
and in revised form December 1, 1995
Accepted for publication December 4, 1995
© 1996 by the International Society of Nephrology
other than a successful kidney transplant, it has been reported
that home hemodialysis provides the best quality of life, the most
independence and the best opportunity for rehabilitation for
ESRD patients [4, 5]. The difference in survival between home
and center hemodialysis patients often has been attributed to
patient selection, as home hemodialysis patients in general differ
from patients treated in facilities in characteristics such as age,
race, sex, and cause of ESRD—all factors with significant impact
on survival.
Selection of patients to home or center hemodialysis may not
just depend on age, sex and cause of ESRD. Patients may also be
selected based on the comorbid conditions present when they start
treatment. Comorbid conditions such as ischemic heart disease,
cerebrovascular disease, and the patient's nutritional status also
substantially alter the risk of death. The magnitude of this excess
risk has been described for incident hemodialysis patients after
adjustment for differences in age, sex and race using the Cox
proportional hazards model [6]. This technique can be used to
compare two groups of patients while adjusting for the effect of
differing frequencies of known comorbid conditions.
The goals of the present study were to determine (1) whether
better survival rates reported with home hemodialysis could be
explained by differences in patient characteristics and comorbid
conditions between patients treated at home and in hemodialysis
centers, and (2) the magnitude of the relative risk while adjusting
for these factors. The investigation was made possible by the
availability of data from the USRDS Special Study of Case Mix
Severity, a national random sample of dialysis patients starting
treatment in 1986 to 1987. Data from this Special Study have also
been used in a similar study comparing mortality between CAPD
and hemodialysis patients [7].
Methods
Data collection
Data were obtained from the USRDS Special Study of Case
Mix Severity Standard Analysis File. This file contains informa-
tion abstracted in 1989 from a sample of 4,892 patients who
started treatment for ESRD in 1986 and 1987. The sampling
process and database construction have been described in detail
elsewhere [8]. All patients in the study were Medicare-entitled for
dialysis services within 90 days or less of the onset of ESRD. Data
were abstracted by staff of the 18 ESRD Networks, under contract
with the Health Care Financing Administration (HCFA). The
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data collection form was developed and tested by the USRDS
Coordinating Center (USRDS CC), the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) and
HCFA.
Patients from each of the 18 ESRD Networks were selected
using a national randomized two-stage sampling procedure. In the
first stage, the USRDS CC selected a weighted sample of 291
dialysis centers from all units nationwide with a probability
proportionate to the size of the facility. To facilitate abstraction of
data from patient records, this sample of dialysis centers was
limited to those dialysis units located within one day's travel from
the respective Network office. Individual patients within each
center were sampled at random and the number of patients from
each center was proportional to the facility's census.
Data collected included patient identifiers, information on
health insurance, presence or absence of a variety of comorbid
conditions within ten years prior to diagnosis of ESRD, physical
characteristics (height, weight, nutritional status, blood pressure)
measured within two to six weeks of the onset of ESRD, dialysis
treatment modality on day 30 of ESRD, prescribed dose of
dialysis, date of death or transplantation, psychosocial status at
onset of ESRD, and ESRD-related laboratory data. A copy of the
data abstraction form was published as Appendix B of the
USRDS 1994 Annual Data Report [9]. Data collected by abstrac-
tion were supplemented from the USRDS database which con-
tains longitudinal data on all Medicare ESRD patients in the
United States from 1977 to the present. Most of these data were
derived from the HCFA Program Management and Medical
Information System. Supplemental data included date of first
dialysis and date of death or transplantation. Data from the
USRDS were based on a May 1993 update of the HCFA file
sources, and were used to determine survival and transplant status
of patients as of December 31, 1992.
Analytical methods
The analysis compared the mortality for home hemodialysis
patients with that of patients treated by center hemodialysis, using
the Cox proportional hazards technique [10]. Comparisons of
descriptive parameters such as frequencies and means between
groups were made using Student's t-test. The analysis used an
intent-to-treat model with adjustment for age, sex, diabetes and
comorbid conditions because the primary aim was to determine
the effect on mortality of patient assignment to home hemodial-
ysis at the onset of ESRD compared to center hemodialysis. An
intent-to-treat analysis was felt to provide the best information to
help the individual patient and their physician choose between
center and home hemodialysis.
Patients were classified to three groups based on the modality
of treatment at 30 days after onset of ESRD: (1) center hemodi-
alysis; (2) home hemodialysis currently in home training; and (3)
home hemodialysis already receiving treatment at home. There
was concern about possible misclassification of the patients
treated at home. Since home hemodialysis training generally takes
6 to 12 weeks, it appeared likely that at 30 days after onset of
ESRD training for home hemodialysis would not be completed.
Thus, patients classified as home hemodialysis who were already
receiving treatment at home 30 days after onset of ESRD would
likely have been receiving dialysis from a nurse visiting the home.
At the time of the study such services were being offered by at
least one large proprietary corporation. Such patients would likely
have significantly greater morbidity and thus bias the outcome
against home hemodialysis. Patients identified as being in home
hemodialysis training were less likely to be misclassified, since
patients requiring nurse-assisted dialysis in the home ordinarily
would have received brief or no training. To avoid this potential
misclassification bias, the primary analysis was therefore a com-
parison of center hemodialysis patients with only those home
hemodialysis patients who were in training on day 30 after the
onset of ESRD. Patients on peritoneal dialysis and all those
transplanted within 30 days of the start of ESRD treatment were
excluded from the analysis.
The analysis was adjusted for the confounding effects of patient
age, sex, race and disease causing ESRD. The age of home
hemodialysis patients ranged from 18 to 90 years. Patients
younger than 18 years and older than 90 years were excluded from
the sample so that the age range in the center hemodialysis group
was comparable to that of the home hemodialysis patients. Within
this range the effect of age was adjusted for by including ge at
onset of ESRD as a covariate in the proportional hazard models.
Patients were stratified on sex, race, and diabetes mellitus as a
cause of ESRD. In view of the relatively small number of home
hemodialysis patients in the sample, the number of strata in the
analysis had to be limited. There were two strata for race: white
patients and a composite race category consisting of black and
Native American/Alaskan Native patients. Asians (not found in
the home hemodialysis sample) and any patients whose race was
unknown were excluded from the study. Patients were stratified
on diabetes as a cause of ESRD because of the known outcome
differences between diabetic and nondiabetic ESRD patients.
Follow-up information through December 1992 was available
on patients in the sample. Observations were censored at 1,500
days into the study or at the date of death or transplantation,
whichever came first. As this was an intent-to-treat model, follow
up was not censored at change of dialysis modality. Observations
were censored at 1,500 days after the date of first treatment (more
than 4 years of follow-up) because by this time substantial
switching of dialysis modality might have occurred and at trans-
plantation as it is a desired change. The dependent variable in the
proportional hazards model therefore measured the time in days
from 30 days after the start of ESRD treatment to the date of
death or transplantation or to the end of follow-up at 1500 days.
As reported previously, information on 25 comorbid conditions
was collected for the USRDS Special Study Of Case Mix Severity
1992 [8, 9]. Comorbid conditions used in the present model were
selected on the basis of either (1) a priori hypotheses about their
importance in explaining differences in mortality between the two
groups of dialysis patients, or (2) as a result of analyses of similar
comorbid conditions collected in the USRDS Special Studies Of
Case Mix Adequacy and Severity. These analyses identified the
conditions that were the best independent predictors of mortality
in center hemodialysis patients.
Because of patient selection for home hemodialysis, some of
the comorbid conditions previously found to be predictive of
mortality were likely to be present among home hemodialysis
patients at a substantially different frequency than among patients
treated in a center. In particular, because of selection, it was felt
that patients with a history of cardiac arrest or of neoplasm with
metastatic spread were likely to be underrepresented, if present at
all, among the home hemodialysis patients. This assumption
proved correct on preliminary examination of the data set. The
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frequencies of previous cardiac arrest were 0% and 1% among
home and center hemodialysis patients, respectively, and the
frequencies of a history of neoplasm with metastases were 0% and
2%, respectively. All these patients were excluded from the study
to avoid difficulties in adjusting appropriately for these differ-
ences. Two other variables were present at a substantially lower
frequency in the home hemodialysis population: patients who
were felt to be clinically undernourished (2.5% vs. 14%), and
those with a history of hepatic cirrhosis (0% vs. 2%). These
patients also were excluded from the study.
Information was lacking for one or more covariates for some
patients. If so, numeric variables with missing values such as
serum albumin levels were set to the mean of observed values.
Categorical covariates with missing values were set to zero, as if
the comorbid condition was not present. This avoided excluding
patients with small amounts of missing data from the proportional
hazards model. For certain covariates a "missing variable" was
created to account for a potential different mortality among
subjects with missing data. In the final model, a binary variable set
to one was used to indicate patients for whom a prescribed Kt/V
could not be calculated.
The final proportional hazards model was adjusted by stratifi-
cation for sex, race and diabetes as a cause of ESRD, and adjusted
for the effect of age by inclusion of patient age at the onset of
ESRD as a continuous covariate. The final model included a
covariate indicating those patients treated with home hemodialy-
sis. For these patients comparison to the reference group of center
hemodialysis patients was made by calculation of a relative risk of
death. Additional covariates included obesity, serum albumin
level, current cigarette smoking, prescribed Kt/V or "missing
prescribed Kt/V," and whether the patient had 12 years of
education. Comorbid conditions included as covariates included a
history of stroke, myocardial infarction, cardiac arrhythmia, pe-
ripheral vascular disease, congestive heart failure, chronic ob-
structive pulmonary disease, insulin therapy, and inability to walk,
eat or transfer independently. Peripheral vascular disease was
defined as presence of a history of peripheral vascular disease,
amputation, intermittent claudication, or absent foot pulses on
examination. The determination that the patient was obese was
based on information in the medical record from between one
month prior to the onset of ESRD to six weeks after the first
treatment. Calculation of prescribed KtIV used dialyzer-specific
urea clearance derived from the manufacturer's specifications for
in vitro clearance of urea by dialyzer blood flow, prescribed
dialysis time, and patient total body water estimated from height,
weight and sex.
Validity analysis
Preliminary results suggested that among the Case Mix Severity
Study sample the relative risk of death adjusted for age, sex, race
and disease was lower for patients whose intended treatment
modality was home hemodialysis. To ensure the validity of this
observation we sought evidence of such an effect for all home
hemodialysis patients in the United States incident during 1986
and 1987, not just those in the Case Mix Severity Study sample.
The dialysis modality is known for Medicare patients in the
national USRDS census on day 90 after start of renal replacement
therapy. This information is derived from a variety of sources
which include the HCFA ESRD Medical Evidence Form and
Quarterly Dialysis Reports. The accuracy of this assignment of
modality for home hemodialysis patients has been in doubt, as is
stressed by the USRDS each year in its Annual Data Report.
Under the classification system used by the USRDS, at day 90
after ESRD, a patient whose intended modality of treatment is
home hemodialysis could be classified into one of two groups: (1)
training for "self care" hemodialysis and currently being treated in
a dialysis center, (2) treatment at home with hemodialysis.
Currently the USRDS reports only those patients already being
treated at home on the 90th day after starting renal replacement
therapy as home hemodialysis patients. Those patients still in
home hemodialysis training and dialyzing in a center are classified
as center hemodialysis patients, and patients receiving nurse-
assisted dialysis at home can be classified as home hemodialysis
patients. We sought to more accurately define individual home
hemodialysis patients, either in training or dialyzing at home at 90
days, by identifying evidence of training for self care hemodialysis.
We defined adequate training for self care hemodialysis as greater
than nine training sessions over a three month period; three weeks
is a conservative estimate of the time required to train for home
hemodialysis.
For each patient we searched the first two Quarterly Dialysis
Reports after the date of onset of ESRD for evidence of billing for
training sessions for self care dialysis. Patients who had received
self care training fell into three groups: (1) currently dialyzing in
a dialysis center while training for self care hemodialysis; (2)
trained and performing hemodialysis in a center; or (3) trained
and performing self care hemodialysis at home. There was no
method to differentiate which of the patients training for self care
were training for treatment at home as opposed to self care in a
dialysis unit. All the categories of self care hemodialysis whether
at home or in a center were therefore combined. Consequently
the primary analysis was a comparison of the relative risk of death
of patients with training for self care hemodialysis either at home
or in a dialysis unit with that of center hemodialysis patients.
The same age, race and treatment modality exclusion criteria
were used in this analysis as were used in the analysis based on the
Case Mix Severity Study sample. A similar proportional hazards
model, with adjustment by stratification for sex, race and diabetes
and with age included as a continuous covariate, was employed.
The other covariate in the model indicated those patients with
training for self care hemodialysis. There was no adjustment for
comorbid conditions as this information was not collected on a
nationwide basis during 1986 and 1987.
Results
Sample description
In the Case Mix Severity Study sample the intended mode of
treatment was identified as center hemodialysis for 3,102 patients,
and as home hemodialysis for 70 patients who were in training at
30 days after the onset of ESRD. Overall, home hemodialysis
patients were younger (49 vs. 59 years), less likely to have diabetes
as a cause of ESRD (14% vs. 30%), more likely to be white (64%
vs. 59%) and male (60% vs. 51%). The relative frequencies of
these parameters and of the comorbid conditions which were
present at the start of ESRD treatment and used in the final
model are shown in Table 1. Statistically significant differences
between the groups are also indicated in the table. Most of the
comorbid conditions were present at a lower frequency in patients
treated by home hemodialysis.
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Table 1. Patient characteristics and comorbidity in study population, 5
data from USRDS Case Mix Severity Study 1986—1990
Patient characteristics!
comorbid factors
Center HD
(N = 3102)
Home HD
(N = 70)
Age years 59 16° 49 16°"'
White race % 59 64
Female sex % 49 40
Diabetes as a cause of ESRD % 30 14"
Active insulin therapy % 22.3 14.3
Active smoker % 16.7 12.9
Arrhythmia % 10.1 14.3
Chronic obstructive pulmonary disease %
Congestive heart failure %
11.2
38.6
14.3
24.3"
Less than 12 years education %
Myocardial infarction %
26.9
13.5
20.0
4.3"
Obese % 22.5 11.4"
Peripheral vascular disease % 17.8 12.9
Stroke % 10.1 2.9"
Unable to eat independently % 2.3 2.9
Unable to transfer independently % 9.2 8.6
Unable to walk independently % 9.3 4.3
Prescribed Kt/V 1.00 0.44° 1.02 0.43°
Serum albumin g!dl 3.5 0.5a 3.6 0.6°"'
° Data represent mean standard deviationbSignificantly different from center HD at P < 0.05
Table 2. Relative risk ratios for patient characteristics and comorbid
factors included in final proportional hazards model, USRDS Case Mix
Severity Study 1986—1990
Patient characteristic!
comorbid factor Relative risk P value
Home HD training at day 30 0.58° 0.03
Age (for each additional 10 years)
Arrhythmia
1.40
110b
<0.001
0.1
Active insulin therapy 1.30" <0.001
Chronic obstructive pulmonary disease 1.18" 0.03
Congestive heart failure 1.20" 0.001
Myocardial Infarction 1.42" <0.001
Peripheral vascular disease 1.14" 0.03
Active smoker 121b <0.01
Less than 12 years education 0.96" 0.49
Obese 081b <0.01
Prescribed Kt/V (per 0.4 increase) 1.00 0.92
Missing prescribed Kt!V 1.01 0.80
Serum albumin (per 0.2 g/dl increase)
Stroke
0.92
1.27"
<0.001
<0.01
Unable to eat independently 1.22" 0.19
Unable to transfer independently
Unable to walk independently
1.15"
1.15"
0.21
0.22
° Relative to reference group of center hemodialysis patients
"Relative to reference group of all patients without this factor
Relative mortality risks
The adjusted mortality risks associated with patient character-
istics and comorbid conditions are shown in Table 2. For each
characteristic or comorbid condition, an adjusted risk ratio is
expressed relative to a selected reference group that is assigned a
mortality risk of one. For example, for the variable "myocardial
infarction" the at risk group is all patients with a history of
myocardial infarction in the ten years prior to the start of ESRD
treatment, and the reference group is all patients who do not have
a history of myocardial infarction recorded. The relative risk of
1.42 indicates that the mortality rate in patients with a history of
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Fig. 1. Relative mortality risk with 95% confidence intervals for patients in
home hemodialysis training U N = 70) or dialyzing at home (, N = 9)
at day 30 after ESRD, showing the effect of adjustment for age, seç race and
diabetes mellitus. The dotted line indicates the relative mortality risk for
those patients treated with center hemodialysis (N = 3102) who are the
reference group. The symbol (*) indicates those values of relative risk
which are significantly different from the reference group (P < 0.05). Data
are from USRDS Case Mix Severity Study for patients incident in 1986 to
87 with follow-up starting from day 30 after ESRD.
myocardial infarction was 42% higher than for patients without
such a history. By means of the Cox proportional hazards model,
this comparison is made while holding the effects of all other
variables in the model constant.
The results of the analysis in the Case Mix Severity Study
sample are shown in Figure 1. The bar on the left shows the
relative risk for home hemodialysis patients in comparison to the
reference group, center hemodialysis patients, without any adjust-
ment for patient characteristics or comorbid conditions. The
relative risk ratio is 0.37, indicating a 63% reduction in the risk of
death for the home hemodialysis patients [P < 0.001; 95%
confidence interval (95% CI) 0.22, 0.601. When this comparison is
controlled for the effects of age, race, sex, and disease causing
ESRD, but not allowing for the effect of comorbid conditions, the
relative risk increases to 0.56 (P = 0.02; 95% CI 0.34, 0.92). The
relative risk of 0.56 for home hemodialysis indicates that if the age
distribution in this group were similar to that of the center dialysis
patients, home hemodialysis would be associated with a 44%
reduction in mortality risk. As would be expected, increasing age
is associated with an increased mortality rate. There is a 48%
higher mortality risk for each additional decade of life (RR =
1.48, P < 0.001).
When the Cox proportional hazards model included additional
adjustment for patient characteristics and for the effect of comor-
bid conditions, home hemodialysis was associated with a relative
risk of 0.58 (P = 0.03, 95% CI 0.35, 0.95). Even after adjustment
for comorbid conditions, the risk of mortality for home hemodi-
alysis patients was 42% lower than for patients treated in hemo-
dialysis centers. Introducing adjustment for comorbid conditions
explains little of the lower mortality with home hemodialysis as
the relative risk of death only changes from 0.56 to 0.58. Most of
the improvement in mortality with home hemodialysis is not
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Months alive from day 30 after ESRD
Fig. 2. Cox estimates of survival using an intent-to-treat model for patients in
home hemodialysis training at day 30 after onset of ESRD (——, N = 70)
compared to center hemodialysis patients (—, N = 3102) after adjustment
forage, sex, race, diabetes and comorbid conditions (P = 0.03). The curves
are for patients with overall average characteristics. Data are from
USRDS Case Mix Severity Study for patients incident in 1986 to 87 with
follow-up from day 30 after ESRD.
explained by this model despite covariate controls for age and
comorbid factors and stratification on sex, race and diabetes.
Figure 2 shows the result for the full proportional hazards
model, adjusted for age, sex, race, diabetes and comorbid condi-
tions and presented as a survival curve. The proportionality of the
Cox proportional hazards model was checked by using a time
dependent covariate for each time point on the curve. The
assumption of proportionality proved to be valid. The more
obvious stepwise decline in the home hemodialysis group occurs
as a result of the small sample size. By 1,500 days 16 patients
(23%) in the home hemodialysis group had died and 18 (26%)
had been censored due to transplantation. In the center hemodi-
alysis group by 1,500 days 1,644 patients (53%) had died and 453
(15%) had been censored due to transplantation. This disparity in
the proportion censored due to transplantation in the two groups
occurs because of the 10 years difference in average age between
home and center hemodialysis patients. When only those patients
under 55 years of age at onset of ESRD were considered, the
proportion censored due to transplantation was equal in each
group (35%) and the relative risk of death for home hemodialysis
training adjusted for age, race, sex, diabetes and comorbid
conditions declined to 0.22 (P = 0.01).
Sensitivity analysis
A separate analysis examined the effect of including in the
primary model the nine patients who were already receiving
hemodialysis at home 30 days after the onset of ESRD. As
previously noted, these patients were excluded initially because of
possible misclassification into this category of those patients
receiving nurse-assisted hemodialysis at home. Data were ana-
lyzed in the same fashion as above, considering these two sub-
categories of home hemodialysis patients separately and then
combined. When compared to center hemodialysis patients, the
age, race, sex, and diabetes adjusted relative risk of death for
these nine patients was 1.57 (P = 0.32, 95% CI 0.65, 3.79). This
decreased to 1.25 (P = 0.62) after adjustment for comorbid
Fig. 3. Relative mortality risk with 95% confidence intervals for self care
hemodialysis with training (N = 418) and without training (N = 1184),
adjusted for age, sex, race and diabetes mellitus. The dotted line indicates
the risk for those patients treated in a hemodialysis center and not
practicing self care (N = 43122) who are the reference group. Data are
from the USRDS census of Medicare patients incident during 1986 to 87
with 1500 days follow-up from determination of dialysis modality at day 90
after ESRD.
conditions, implying these patients had higher overall co-morbid-
ity than the center hemodialysis patients. This suggests the
original assumption was correct that those patients already dia-
lyzing at home within 30 days of starting ESRD treatment had a
higher degree of co-morbidity. When both categories of home
hemodialysis patients were considered together, the age-adjusted
relative risk was 0.66 (P = 0.06, 95% CI 0.43, 1.02). This was
unchanged after adjustment for comorbid conditions.
Validity analysis
Once similar exclusion criteria of age, race and dialysis modality
were applied to all patients in the national USRDS database, a
total of 43,281 center hemodialysis patients were identified. A
further 418 self care patients were identified who fulfilled the
minimum training requirement, 133 of these were being treated at
home and 285 were being treated in center. Of the patients being
treated in dialysis centers, 63 were performing self care and 222
were training for self care hemodialysis at home or in a center.
The relative risk of death for the 418 self care patients with
training identified in the national USRDS database compared to
the reference group of 43,122 center hemodialysis patients was
0.78 (P 0.02, 95% CI 0.67, 0.90). The 1184 patients being
treated with self care hemodialysis but without evidence of
training had a relative risk of 1.04 (P = 0.26, 95% CI 0.98, 1.12).
These results are illustrated in Figure 3.
When the self care group dialyzing in a center at day 90 was
subdivided by number of training sessions, the relative risk for
those patients with training (N = 285) was 0.76 (P = 0.003, 95%
CI 0.63, 0.91) and for those without training (N 166) was 1.02
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(P = 0.89, 95% CI 0.82, 1.26). For those patients being treated at
home with evidence of training (N = 133) the relative risk was
0.81 (P = 0.13, 95% CI 0.62, 1.06), and for those dialyzing at home
without evidence of training (N = 1085) the relative risk was 1.05
(P = 0.25, 95% CI 0.97, 1.14). In all cases the reference group was
identical, being the 43,122 center hemodialysis patients not prac-
ticing self care.
Discussion
A number of previous studies have shown advantages for
patients treated by home hemodialysis as compared to those
treated by center hemodialysis and by CAPD. These differences
include a lesser mortality [2, 3] and better quality of life, increased
independence and more opportunity for rehabilitation [4, 5].
However, many have regarded these differences as merely a
reflection of the effects of selection of patients with fewer
comorbid conditions to home hemodialysis or the experience of a
single program. This is the first study to analyze the differences in
mortality risk between home hemodialysis and center hemodial-
ysis adjusting for comorbid conditions and using a nationwide
random sample of patients. It is also the first such study to sample
patients starting treatment over a relatively short time period, so
being less sensitive to any improvements or other changes in
treatment for the two groups with time. The results show a striking
benefit of reduced mortality risk for patients selected for treat-
ment by home hemodialysis. Confirmatory evidence for this
finding is provided by a further study among the Medicare entitled
hemodialysis patients in the national USRDS database. Those
patients with evidence of training for self care hemodialysis had a
22% reduction in the risk of death after adjustment for the effects
of age, sex, race and diabetes as a cause of ESRD.
Both these analyses used an 'intent-to-treat' model since its
results are most useful for advising patients. It is recognized that
some patients will likely switch between center and home hemo-
dialysis after the study assignment of dialysis modality. Patients
for whom home hemodialysis is planned may not complete
training and may stay on center hemodialysis; patients who finish
training and start hemodialysis at home may become ill and
transfer to center hemodialysis. If they die after changing modal-
ity, under the intent-to-treat method of analysis, their death would
still be considered as a death occurring on home hemodialysis, not
center hemodialysis. Part of the higher mortality due to center
hemodialysis is in fact then attributed to home hemodialysis.
Conversely, the improved survival among those patients who had
switched to home hemodialysis would be attributed to center
hemodialysis. The effect of patients switching dialysis modality is
to reduce the apparent outcome difference between the two
treatments, Therefore, our use of an intent-to-treat analysis
method in this study may have lead to a conservative estimate of
the difference in survival between the two treatments, the real
effect may be greater than reported.
There are several possible explanations for the difference
between the two treatments. First, there is undoubtedly substan-
tial selection of the type of patients who enter home hemodialysis
training. Home hemodialysis training requires a major commit-
ment of time and effort by the patient and their hemodialysis
partner. The most motivated patients and families tend to be
selected and such patients are more likely to be compliant with
medication, diet and dialysis prescription. Selection may also
occur based on the severity of comorbid conditions at onset of
ESRD. In this study, when adjusting for co-morbidity, we assumed
each comorbid condition was either present or absent. There may
be a gradation of severity of disease that such a simple response
may not provide sufficient information to adjust for fully. For
example, patients in both groups may have a history of coronary
artery disease, but in general the home hemodialysis group may
contain patients with less severe disease. The present findings may
be in part a result of selection of home hemodialysis patients with
less severe abnormalities in coronary artery, cerebral or periph-
eral vascular disease. Such selection might be detected by a more
complete measure of co-morbidity. However, the magnitude of
the observed effect for the home hemodialysis group is such that
a more refined method of adjusting for co-morbidity is likely to
explain only a portion of the observed difference between the two
groups.
Perhaps other unmeasured comorbid conditions are important.
We did include variables which we hypothesized could be impor-
tant in explaining differences between the two groups. For exam-
ple, we thought that socioeconomic status and the highest educa-
tional level the patient achieved could differ between the center
and home hemodialysis patients. We included a covariate for
estimated household income by using data from the US Bureau of
the Census to determine the median household income for the zip
code area of each patient's residence. When estimated household
income derived in this fashion was analyzed as a continuous
covariate, no statistically significant effect was found. As an
individual's income is likely to show substantial collinearity with
the highest achieved level of education, the income variable was
removed from the final model.
Could the difference be due to factors other than co-morbidity?
A possible explanation for the difference between the patient
groups is adequacy of dialysis. In the data set, the prescribed Kt/V
values come from the time when both groups of patients were
dialyzing in a center shortly after starting ESRD treatment. Once
home, patients are not constrained by a rigid facility schedule and
subsequently home hemodialysis patients may have had a higher
dose of dialysis (KtIV) on average as a result of longer dialysis
times. At the time these data were collected, there was increasing
concern about the relatively high mortality in United States
dialysis patients compared with patients in Europe and Japan [111.
Based on the same database as this study, it was shown that the
prescribed dose of hemodialysis was low relative to European
patients [12]. Thus, many center hemodialysis patients eventually
would be underdialyzed, resulting in an increased mortality during
the relatively long observation period of this study. Increased
attention is now being paid to dialysis adequacy among hemodi-
alysis patients. In this analysis the prescribed Kt/V among center
hemodialysis patients during 1986 to 1987 was 1.0, while recent
data from Wave 1 of the USRDS Dialysis Morbidity and Mortality
Study suggests that by 1993 the prescribed Kt/V among incident
patients had risen to 1.23 (unpublished observation). If the dose
of dialysis has risen disproportionately among center hemodialysis
patients the difference we observed in mortality between the two
hemodialysis modalities may currently be narrowing.
Could the better survival with home hemodialysis be a result of
the treatment environment? In patients with type 1 diabetes
mellitus, the best results are found in those patients who know
most about their own treatment and who can make appropriate
adjustments themselves to achieve optimal control. In the elderly,
those who remain active despite their infirmities adjust much
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better to aging than those who become inactive and more
dependent on others for their needs and satisfactions [13]. Twenty
years ago Blagg and Scribner [141pointed out the importance of
fostering independence and avoiding loss of control on the part of
the dialysis patient and development of what has been called
"learned helplessness" [15]. Independence is best encouraged by
allowing patients to take responsibility for their own well-being.
This is maximized by training patients to perform self care hemodi-
alysis at home. We would speculate that home dialysis removes
patients from the dialysis center where nurses and physicians tend to
create dependence, and where the presence of other patients with
serious medical problems lead them to develop an image of them-
selves as ill. As a result of doing their own dialysis, home hemodial-
ysis patients may become more knowledgeable about their illness and
treatment and so are more likely to receive adequate dialysis and
therefore live longer than patients dialyzing in a center.
We find a substantial survival advantage associated with hemo-
dialysis at home compared to hemodialysis in a dialysis center
which persists after adjustment for patient characteristics and comor-
bid conditions. An epidemiological study can only show associations
but cannot prove causation. The selection of patients to home
hemodialysis is such that any retrospective adjustment of risk based
on patient characteristics and comorbid conditions will always be less
than perfect. The observation of a 42% lower mortality risk for home
hemodialysis patients suggests that a true advantage likely exists.
However, only a prospective study with randomization of potential
home hemodialysis patients to one of the two modalities can provide
definitive confirmation of this observation.
Reprint requests to John D. Woods, M.B., MRCP, The University of
Michigan Kidney Epidemiology and Cost Center, 315 W Huron Street, Suite
240, Ann Arbor, Michigan 48103, USA.
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